Crosstalk between ERα and Receptor Tyrosine Kinase Signalling and Implications for the Development of Anti-Endocrine Resistance.

Autor: Montaser RZ; Faculty of Health and Medical Sciences, University of Surrey, Guildford, Surrey GU2 7XH, UK. rugaia.montaser@gmail.com., Coley HM; Faculty of Health and Medical Sciences, University of Surrey, Guildford, Surrey GU2 7XH, UK. h.coley@surrey.ac.uk.

Publikováno v: Cancers [Cancers (Basel)] 2018 Jun 20; Vol. 10 (6). Date of Electronic Publication: 2018 Jun 20.

The role of the tumor microenvironment in endocrine therapy resistance in hormone receptor-positive breast cancer.

Autor: Jie Yuan, Li Yang, Zhi Li, Hua Zhang, Qun Wang, Jun Huang, Bei Wang, Mohan, Chakrabhavi Dhananjaya, Gautam Sethi, Geng Wang

Publikováno v: Frontiers in Endocrinology; 2023, p1-10, 11p

ERα36 as a Potential Therapeutic Target for Tamoxifen-Resistant Breast Cancer Cell Line Through EGFR/ERK Signaling Pathway.

Autor: Li, Guangliang, Zhang, Jing, Xu, Zhenzhen, Li, Zhongqi

Publikováno v: Cancer Management & Research; Jan2020, Vol. 12, p265-275, 11p